Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

Medical University Vienna, Vienna

University Multiprofile Hospital for Active Treatment, Plovdiv

Specialized Hospital for Active Treatment, Sofia

Multiprofile Hospital for Active Treatment, Varna

Vivantes Hospital in Friedrichshain, Berlin

SRH Kurpfalzklinik Heidelberg GMBH, Heidelberg

Hungarian National Healthcare Center, Budapest

University of Debrecen, Medical and Health Science Center, Debrecen

University Teaching Hospital in Bialystok, Teaching Department of Hematology with a Subdepartment of Vascular Diseases, Bialystok

University Clinical Center, Teaching Department of Hematology and Transplantology, Gdansk

Nicolaus Copernicus Municipal Specialist Hospital, Department of Hematology, Torun

Institute of Hematology and Transfusion Medicine, Depart. of Hemostatic Disorders and Internal Diseases, Warsaw

Sanador SRL, Bucharest

Louis Turcanu Emergency Clinical Children's Hospital, Timișoara

University Hospital Saint Cyril and Metod, Bratislava

University Hospital Martin, Department of Hematology and Transfusiology, Martin

Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center, Basingstoke

Royal London Hospital, Barts and the London Hemophilia Center, London

Manchester Royal Infirmary, Department of Clinical Hematology, Manchester

Royal Hallamshire Hospital, Sheffield